P1053 (10131): A Phase II Randomized, Open-Label Study to Evaluate the Safety and Effectiveness of Two Antiretroviral Therapeutic-Strategies: A Dual PI-Based-HAART Regimen vs. an Multi-NRTI ART Regimen in ART-Experienced Children and Youth Who Have Experienced Virologic Failure

Study Status Study Restriction

Concluded

United States

Sites where the study was implemented:

CRS ID Site Name City Country

5026

Mt. Sinai Medical Center

New York

United States of America

Study contacts:

CTS: IMPAACT Operations Center

Department of Health and Human ServicesNational Institutes of Health

Funded by the National Institute of Allergy and Infectious Diseases, the Eunice Kennedy Shriver National Institute of Child Health and Human Development, and the National Institute of Mental Health of the US National Institutes of Health, US Department of Health and Human Services.